{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "Leverage (3x)",
        "Inverse exposure",
        "Synthetic replication with unfunded swaps",
        "Daily reset compounding effect",
        "High risk profile (7/7)",
        "Complex index tracking (MSFXSM Triple Short US Dollar/Euro Index)"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex due to multiple factors: 1) It uses 3x leverage with inverse exposure, which creates significant volatility and risk amplification. 2) The synthetic replication method relies on unfunded swaps, introducing counterparty risk. 3) The daily reset mechanism creates compounding effects that make performance unpredictable over longer periods. 4) The underlying index (MSFXSM Triple Short US Dollar/Euro Index) is inherently complex due to its leveraged and inverse nature. 5) The product is rated 7/7 for risk, indicating very high potential losses. 6) The fact sheet explicitly states it's only suitable for sophisticated/informed investors who understand leverage and daily rebalancing. While the product is UCITS-eligible, it is not UCITS-compliant, and the documentation emphasizes its complexity and suitability only for short-term trading. The combination of these factors clearly meets MiFID II's criteria for a complex financial instrument.",
    "confidence": 95
}